Vaccine Targeting KRAS in Pancreatic and Colorectal Cancer Shows Promise ( www.mskcc.org )
A new vaccine shows encouraging early results as a potential off-the-shelf treatment for certain patients with pancreatic or colorectal cancer, according to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK). The vaccine targets tumors with mutations (or changes) in the KRAS gene, a driving force in...
![](https://mbin.grits.dev/media/cache/resolve/entry_thumb/a5/47/a547d100b8beaa2a725fce06d0b646aa9d4801cb94ba0b93e81efa8a426539e7.jpg)